On this page you will find our recommendations sorted by BNF chapter.

Appraisal Reports are available to stakeholders on request.

Where a decision is >24 months old; these are highlighted in red. If you are a clinician working within the NTAG region and would like to prioritise an old decision for re-review please contact the professional secretary on nuth.nyrdtc.rxsupp@nhs.net

Title Documents Decision Date

Updated

26/06/2023
NENC Clinical Commissioning Policy Baricitinib for patients hospitalised due to COVID-19 (adults and children aged 2 years and over) NENC Clinical Commissioning Policy Baricitinib for patients hospitalised due to COVID-19 (adults and children aged 2 years and over) Approved by NENC Medicines Subcommittee 20/06/2023

Updated

07/06/2022
NTAG Decision Summary - Biosimilars statement - June 2022 Recommendation Recommended 07/06/2022